Home › Parkinson's Disease › NCT07725315
Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain Stimulation
Recruiting
Who can join
Ages 30 to 80 · All sexes
Full eligibility criteria
Inclusion Criteria: * Age between 30-80, patient has elected to undergo DBS surgery as part of routine care, cleared for deep brain stimulation surgery as part of routine care by the movement disorders committee. Refractory motor symptoms such as dyskinesias, wearing off, and/or motor fluctuations, causing significant disability, despite reasonable attempts at medical management, as determined by the consensus DBS committee, able to walk, Patient is available for follow-up over the length of the study Exclusion Criteria: Patient's insurance will not cover the costs of surgery with investigational devices, Medical contraindications such as current uncontrolled hypertension, heart disease, coagulopathy, or other conditions contraindicating DBS surgery or stimulation, self-report of lack of clear levodopa response, requires a walker or wheelchair for mobility \-
About the study
The purpose of this pilot study is to assess changes in thinking and movement after deep brain stimulator implantation. The study will also examine whether these changes are related to the risk of falls.
What is being tested
- DBS as part of standard of care (behavioral)
Sponsor: University of Alabama at Birmingham · Participants: 20 · Started: Aug 1, 2026
Contact the study team
- Christopher Hurt, PhD · Phone: 2059345817
Official record on ClinicalTrials.gov — NCT07725315
Locations in the U.S.
| Alabama | UAB WHARF at Lakeshore, Homewood |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.